These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20011660)

  • 1. ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis.
    Perron JC; Dodd J
    PLoS One; 2009 Dec; 4(12):e8198. PubMed ID: 20011660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductive specification and axonal orientation of spinal neurons mediated by divergent bone morphogenetic protein signaling pathways.
    Perron JC; Dodd J
    Neural Dev; 2011 Nov; 6():36. PubMed ID: 22085733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural distinctions in BMPs underlie divergent signaling in spinal neurons.
    Perron JC; Dodd J
    Neural Dev; 2012 May; 7():16. PubMed ID: 22559862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotropic signaling by BMP7 requires selective interaction at a key residue in ActRIIA.
    Perron JC; Rodrigues AA; Surubholta N; Dodd J
    Biol Open; 2019 Jul; 8(7):. PubMed ID: 31208997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
    Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
    J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    Yu PB; Beppu H; Kawai N; Li E; Bloch KD
    J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells.
    Yu PB; Deng DY; Beppu H; Hong CC; Lai C; Hoyng SA; Kawai N; Bloch KD
    J Biol Chem; 2008 Feb; 283(7):3877-88. PubMed ID: 18042551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
    Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
    J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-2 and -4 produced by vascular smooth muscle cells from atherosclerotic lesions induce monocyte chemotaxis through direct BMPRII activation.
    Simões Sato AY; Bub GL; Campos AH
    Atherosclerosis; 2014 Jul; 235(1):45-55. PubMed ID: 24814649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
    Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
    Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
    Aykul S; Martinez-Hackert E
    J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.
    Cassar L; Nicholls C; Pinto AR; Chen R; Wang L; Li H; Liu JP
    Protein Cell; 2017 Jan; 8(1):39-54. PubMed ID: 27696331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-specific systemic over-expression reveals novel in vivo effects of the soluble forms of ActRIIA, ActRIIB and BMPRII.
    Yamawaki K; Ueda S; Okada T; Oshima T; Kakitani M; Kato T; Tomizuka K
    PLoS One; 2013; 8(10):e78076. PubMed ID: 24205096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
    Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
    FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
    PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP2-induced chemotaxis requires PI3K p55γ/p110α-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5β recruitment at the cytocortex.
    Hiepen C; Benn A; Denkis A; Lukonin I; Weise C; Boergermann JH; Knaus P
    BMC Biol; 2014 May; 12():43. PubMed ID: 24885555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.
    Kudo TA; Kanetaka H; Watanabe A; Okumoto A; Asano M; Zhang Y; Zhao F; Kano M; Shimizu Y; Tamura S; Hayashi H
    Tohoku J Exp Med; 2010 Oct; 222(2):121-9. PubMed ID: 20919447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages.
    Rocher C; Singla DK
    PLoS One; 2013; 8(12):e84009. PubMed ID: 24376781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells.
    Hu M; Cui F; Liu F; Wang J; Wei X; Li Y
    Int J Oncol; 2017 Jan; 50(1):193-202. PubMed ID: 27959431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.